Table 3.
Adverse event | Patients, n (%) |
---|---|
Grade 3/4 adverse events | 35 (44.9) |
Neutropenia | 17 (21.8) |
Asthenia | 7 (8.9) |
Hypertension | 6 (7.6) |
Febrile neutropenia | 4 (5.1) |
Proteinuria | 3 (5.1) |
Mucositis | 3 (3.8) |
Thrombocytopenia | 2 (2.5) |
Peripheral neuropathy | 2 (2.5) |
Bleeding | 2 (2.5) |
Thromboembolic disease | 1 (1.2) |
Brain stroke | 1 (1.2) |